Alan Yu

Health networks say they are now better prepared with COVID-19 tests and precautions, so can slowly bring patients for in-person visits and procedures.

The announcement was big news for Pa. hospitals, which has seen other states get the antiviral — the first somewhat effective coronavirus treatment.

The federal government sent its first shipment of 1,200 doses of investigational antiviral drug remdesivir to the Pennsylvania Health Department on Tuesday.

Gilead has donated its existing supply, to be distributed by AmerisourceBergen. That company says the government decides which places can get the drug.

Chester County has contracted with Lehigh Valley Genomics, an approved lab in Bethlehem, to monitor the tests and will offer them at two locations.

As Pennsylvania, other places consider tech to track and thwart coronavirus spread, they must balance personal privacy with the need for public health data.

Naturally, she swats at them from time to time, but it’s her job to get to know the little biters better.

Would-be ER visitors are weighing their fear of worsening symptoms with their fear of exposure to the coronavirus. Doctors say that’s not a good thing.

They care for their patients for years sometimes, getting to know their families. Now, a shortage of PPE and a lack of testing puts them all at risk.

Blood donations by African Americans dropped by 50% since mid-March, when many drives were canceled. That affects sickle cell patients seeking a match.

Montgomery and Chester counties want to do more tests in jails and nursing homes, but state and federal regulations are getting in the way.

As doctors treat more and more COVID-19 patients, they are realizing the new coronavirus can affect far more than just a patient's lungs.